Archive for July, 2006

Akorn, Inc. Reports Second Quarter 2006 Revenues Of $12.5 Million … - Business Wire (press release)

Akorn, Inc. Reports Second Quarter 2006 Revenues Of $12.5 Million …Business Wire (press release), CA - 1 hour ago… Seven product approvals were received from the FDA: Brimonidine, Inapsine(R), Orphenadrine, Sufenta(R), Alfenta(R), Amiodarone, and Dilitiazem. …

Read full story

Comments

BDS recalls 'wrong' drug - The Nation Newspaper

BDS recalls 'wrong' drugThe Nation Newspaper, Barbados - 11 hours ago… Amodiaquine was given to patients instead of Amiodarone, the brand-name anti-arrhythmic drug, because by error, the anti-malaria treatment was included in the …

Read full story

Comments

DRUG MIX-UP - The Nation Newspaper

DRUG MIX-UPThe Nation Newspaper, Barbados - 10 hours ago… The patients were given the drug, Amodiaquine, an anti-malaria treatment, instead of Amiodarone, a brand-name anti-arrhythmic drug. …

Read full story

Comments

Robotic minimally invasive cell transplantation for heart failure - The Journal of Thoracic and Cardiovascular Surgery

Robotic minimally invasive cell transplantation for heart failureThe Journal of Thoracic and Cardiovascular Surgery - 1 hour ago… During right single-lung ventilation and antiarrhythmic prophylaxis (amiodarone, 3 mg/kg; lidocaine, 1 mg/kg), we inserted the camera port, 2 instrument ports …

Read full story

Comments

ARYx Signs P&G To $435M Agreement For Lead GI Drug - BioWorld Online

ARYx Signs P&G To $435M Agreement For Lead GI DrugBioWorld Online, GA - 8 hours ago… ARYx has two other drugs in clinical development: ATI-2042, an analogue of amiodarone, in a Phase II atrial fibrillation study; and ATI-5923 in Phase I …

Read full story

Comments

Antiarrhythmics: RSD1235 Woes Reduce Market Potential but Not … - PharmaLive.com (press release)

Antiarrhythmics: RSD1235 Woes Reduce Market Potential but Not …PharmaLive.com (press release), PA - Jul 11, 2006… has experienced a sharp decline in sales over recent years, primarily due to the loss of patent protection for Sanofi-Aventis' Cordarone (amiodarone) in the US …

Read full story

Comments

ICD plus antiarrhythmic drug therapy: Analysis doubts need for … - TheHeart.Org

ICD plus antiarrhythmic drug therapy: Analysis doubts need for …TheHeart.Org, NY - 11 hours agoDallas, TX - Antiarrhythmic agents used with today's implantable cardioverter defibrillators (ICDs), particularly amiodarone, don't raise successful-shock …

Read full story

Comments

Antiarrhythmics: RSD1235 woes reduce market potential but not … - Pharmaceutical Business Review

Antiarrhythmics: RSD1235 woes reduce market potential but not …Pharmaceutical Business Review - 4 hours ago… has experienced a sharp decline in sales over recent years, primarily due to the loss of patent protection for Sanofi-Aventis' Cordarone (amiodarone) in the US …

Read full story

Comments

HIV - New Tablet Formulation Of Kaletra® (lopinavir/ritonavir) … - Medical News Today (press release)

HIV - New Tablet Formulation Of Kaletra® (lopinavir/ritonavir) …Medical News Today (press release), UK - 4 hours ago… Kaletra should not be taken with amiodarone, astemizole, cisapride, dihydroergotamine, ergonovine, ergotamine, methylergonovine, midazolam, pimozide …

Read full story

Comments

Akorn, Inc. Announces Product Approval for Amiodarone … - Genetic Engineering News (press release)

Akorn, Inc. Announces Product Approval for Amiodarone …Genetic Engineering News (press release), NY - Jul 6, 2006Akorn, Inc. (AMEX:AKN) today announced that it has received an ANDA approval for Amiodarone Hydrochloride Injection. The product …

Read full story

Comments

· « Previous entries